Category: News
Weber Study of UV Disinfection Technologies Referenced in Market Research News
David Weber, MD, MPH A study by David Weber, MD, MPH, which offers key insights on UV disinfection technologies, was referenced in a press release that recognizes the global UV disinfection equipment market is expected to reach $6.73 billion by 2025. Weber’s study considered the specifics of manual cleaning, disinfection, and polychromatic actions. Weber is professor of medicine … Read more
COVID Vaccine Updates Feature David Wohl
David Wohl, MD David Wohl, MD, professor of medicine in the division of infectious diseases, was featured in a number of COVID-19 articles the week of September 10-15. NC Reacts to COVID Vaccine Order – News & Observer (September 11, 2021) As political, medical and business leaders in North Carolina show mixed reactions to President Joe Biden’s new COVID-19 mandate, David Woh … Read more
Blue Cross NC, UNC Health Join Forces for New Clinical Study to Improve Food Security, Chronic Health Conditions
Darren DeWalt, MD, MPH, Alice Ammerman, DrPH, and Seth Berkowitz, MD, MPH Blue Cross and Blue Shield of North Carolina (Blue Cross NC) has dedicated $3.2 million for a new, large clinical study to address food insecurity among its at-risk members who also have hypertension. The study will measure how to best help people who are food insecure achieve better health through nutritio … Read more
Together We Care, Department of Medicine–18 Months Into the SARS-CoV-2 Pandemic
Ronald Falk, MD “I’m going to be describing this concept of together we care. An interesting concept but one that I hope at the end of this we can actually think about practicing. That we care about each other and we do it as a community. For we have now been in our department, in our school and health care system, through literally 18 months of this pandemic.” Ronald J. Falk, … Read more
Durham School Board Will Collect Vaccination Data Before Deciding Whether to Mandate Vaccines for its Employees
David Weber, MD, MPH Indyweek covered a recent Durham public school board meeting designed to weigh the pros and cons of requiring mandatory COVID vaccine shots for teachers and staff. The board members opted to develop a plan of action based on data that will indicate what percentage of school employees have already received the vaccine. David Weber, MD, MPH, professor of medici … Read more
Governor Cooper Signs Executive Order Aimed to Expand Access to COVID-19 Antibody Treatment
David Wohl, MD Governor Roy Cooper signed an executive order expanding access to monoclonal antibody treatments that have the potential to prevent people from dying of COVID-19. The emergency-use treatment is used on high-risk COVID-19 patients who experience symptoms within 10 days of testing positive. This treatment is reported to be similar to what was used on former President … Read more
Giselle Corbie-Smith Receives Outstanding Faculty Staff Award
Giselle Corbie-Smith, MD, MSc Giselle Corbie-Smith, MD, Kenan Distinguished Professor in the Departments of Medicine and Social Medicine, has received the 2021 McClinton Outstanding Faculty Staff Award. Corbie-Smith is nationally known for her scholarly work on the inclusion of disparity populations in research and has over a decade of experience in using community engagement to … Read more
The OA Action Alliance, Arthritis Foundation, and CDC Release ‘Action Briefs’ Focused on Osteoarthritis
Leigh Callahan, PhD Newly released Action Briefs now make it easier for employers, insurers, healthcare systems, policy makers, and leaders in other organizations to take specific, practical actions to support their constituents with osteoarthritis. The Osteoarthritis Action Alliance (OAAA), partnering with the Centers for Disease Control and Prevention (CDC) and the Arthritis Fo … Read more
UNC Antibody Treatment Could Reduce COVID-19 Hospitalizations By Nearly 80%
Credit: WRAL Researchers with the University of North Carolina at Chapel Hill are looking into a new treatment for COVID-19. Vice chair of the study, Dr. David Wohl, professor of medicine in the division of infectious diseases, says the monoclonal antibody cocktail is able to attach to the virus and prevent it from hurting people. Watch the report.
Durham’s Brii Biosciences Bets $100M to Advance Possible COVID Therapy
David Wohl, MD A WRAL TechWire report says Brii Biosciences, which has operations in Durham as well as Beijing, has announced its commitment to support a combination therapy called BRII-196/BRII-198. “So far, this therapy and other monoclonal antibodies show effectiveness against the Delta variant, which now accounts for almost all the COVID-19 cases in the U.S.,” said David Wohl … Read more
News and Observer Consults Experts About Attending Large Events
David Wohl, MD As college football stadiums across the nation fill up with cheering fans and limited masking, a Raleigh News & Observer article asks the experts about virus spread. David Wohl, MD, professor of medicine in the division of infectious diseases responded. “Delta is a game-changer (pun intended). This variant is hyper-infectious and hyper-dangerous. That means the … Read more
Weber Explains UV Light, New LARQ Bottle Designed to Deliver Clean Water
David Weber, MD, MPH David Weber, MD, MPH, professor of medicine in the division of infectious diseases, commented on UV light technology, which is used in the LARQ Bottle. The new bottle was designed to give people around the world access to pristine drinking water, easily and sustainably. A news report in King Weekly Sentinel reports the bottle’s technology activates every two … Read more